PageOverview.com
 

Domains targeting keyword metastatic

Keyword metastatic was used in the provided list of websites.

 
Number of websites/domains displayed: 31
Results found: 31
 

Websites discovered:

For Healthcare Professionals | CYRAMZA® (ramucirumab)
http://pageoverview.com/website-report/cyramzahcp.com
CYRAMZA, combined with other medications, is used for the treatment of patients with advanced gastric cancer or GEJ, metastatic non-small cell lung cancer (NSCLC), and metastatic colorectal cancer (mCRC).
  • Expected expiration: August 27th in 2017
  • Creation date: August 27th in 2013
  • Renew date: August 23rd in 2016
Pheo vs Fabulous | A first hand look at my fight & impact with metastatic pheochromocytoma cancer… meanwhile staying my fabulous self!
http://pageoverview.com/website-report/pheovsfabulous.com
A first hand look at my fight & impact with metastatic pheochromocytoma cancer... meanwhile staying my fabulous self!
  • Expected expiration: January 19th in 2019
  • Creation date: January 19th in 2017
  • Renew date: December 20th in 2017
C101 - A Unique Resource for People with Cancer
http://pageoverview.com/website-report/cancer101.org
CANCER101 helps the newly diagnosed, those with metastatic cancer, their families and health care professionals work together to get organized and informed to
  • Expected expiration: February 9th in 2020
  • Creation date: February 9th in 2002
  • Renew date: January 26th in 2017
  • Google Analytics: 39167303-1
OPDIVO® (nivolumab) | Patient Gateway
http://pageoverview.com/website-report/opdivo.com
OPDIVO® (nivolumab) is a prescription medication. Read about its indications, side effects, and more.
  • Expected expiration: November 6th in 2017
  • Creation date: November 6th in 2012
  • Renew date: November 1st in 2016
YERVOY®(ipilimumab) | Consumer | Gateway
http://pageoverview.com/website-report/yervoy.com
YERVOY® (ipilimumab), prescription medication. See Indication, Important Safety Information, and Boxed Warning.
  • Expected expiration: May 8th in 2018
  • Creation date: May 8th in 2009
  • Renew date: May 4th in 2017
Home | Prostate Cancer Matters
http://pageoverview.com/website-report/prostatecancermatters.ca
Knowledge is power. Understand your choices for metastatic prostate cancer.
  • Expected expiration: March 6th in 2018
  • Creation date: March 6th in 2014
  • Renew date: February 20th in 2017
  • Google Analytics: 4635106-55
Home
http://pageoverview.com/website-report/iressa.com
Official site of IRESSA (gefitinib), indicated in Europe for the treatment of adults with locally advanced or metastatic NSCLC with activating mutations of EGFR-TK across all lines of therapy.
  • Expected expiration: August 13th in 2017
  • Creation date: August 13th in 1999
  • Renew date: August 9th in 2016
Metastatic CR Prostate Cancer Treatment - XTANDI® (enzalutamide)
http://pageoverview.com/website-report/xtandihcp.com
Learn about XTANDI® (enzalutamide) capsules indicated for the treatment of patients with metastatic castration-resistant prostate cancer (mCRPC).
  • Expected expiration: July 10th in 2018
  • Creation date: July 10th in 2012
  • Renew date: July 1st in 2015
AIM Biotech - 3D cell culture
http://pageoverview.com/website-report/aimbiotech.com
AIM Biotech offers an easy-to-use, modular platform for incorporating 3D cell culture into your research. AIM chips enable you to co-culture different cell types discrete 3D and 2D compartments, using hydrogels of your choice. Other important parameters
  • Expected expiration: June 16th in 2018
  • Creation date: June 16th in 2011
  • Renew date: June 16th in 2017
  • Google Analytics: 55224757-1
Galil Medical | Cryotherapy Solutions | Ablation of solid tumor cancers | Nerve Ablation for pain management | Cryoablation | Cryosurgery
http://pageoverview.com/website-report/galilmedical.com
Global leader of innovative cryotherapy solutions. Delivering a new era of cryotherapy for minimally invasive, targeted cryosurgical ablation.
  • Expected expiration: April 27th in 2020
  • Creation date: April 27th in 2000
  • Renew date: August 29th in 2016
  • Google Analytics: 45941207-1
Neurosurgery.Brain Tumor.Stroke.Head Injury.Pain.Paraplegia
http://pageoverview.com/website-report/neurosurgery.tv
Neurosurgery.Brain Tumor.Stroke.Head Injury.Pain.Paraplegia
  • Expected expiration: May 18th in 2025
  • Creation date: May 18th in 2006
  • Renew date: December 17th in 2015
  • Google Analytics: 71156232-1
Leiomyosarcoma is a rare cancer
http://pageoverview.com/website-report/leiomyosarcoma.info
Leiomyosarcoma - extensive medical information all levels, written by a doctor for patients and doctors, to educate for effective treatment decisions.
  • Expected expiration: June 10th in 2019
  • Creation date: June 10th in 2002
  • Renew date: May 8th in 2017
OPDIVO® (nivolumab) | Information for Healthcare Professionals
http://pageoverview.com/website-report/opdivohcp.com
Learn more about OPDIVO® (nivolumab). Prescribed medication to treat certain types of cancers. Read about its indications, clinical data and efficacy.
  • Expected expiration: March 3rd in 2018
  • Creation date: March 3rd in 2014
  • Renew date: February 27th in 2017
metastatic.org
http://pageoverview.com/website-report/metastatic.org
  • Expected expiration: May 31st in 2017
  • Creation date: May 31st in 2001
  • Renew date: June 1st in 2016
A treatment for certain colorectal and head and neck cancers | ERBITUX (cetuximab)
http://pageoverview.com/website-report/erbitux.com
Learn about ERBITUX, a treatment for metastatic colorectal cancer as well as certain types of head and neck cancers.
  • Expected expiration: March 1st in 2018
  • Creation date: March 1st in 2000
  • Renew date: February 25th in 2017
Tyme Technologies | Fighting Stage IV Metastatic Cancer
http://pageoverview.com/website-report/tymeinc.com
Tyme Technologies, Inc. is a research and development company focused on creating medicines that utilizes the body’s immune system to treat diseases.
  • Expected expiration: May 19th in 2020
  • Creation date: August 30th in 2013
  • Renew date: May 19th in 2017
  • Google Analytics: 2555965-33
Cancer Care
http://pageoverview.com/website-report/cancercarenews.ca
  • Expected expiration: January 29th in 2018
  • Creation date: January 29th in 2014
  • Renew date: January 12th in 2017
  • Google Analytics: 47477110-23
IRSA - RadioSurgery Association
http://pageoverview.com/website-report/irsa.org
Educational and hospital on Gamma Knife and Linac stereotactic radiosurgery for brain tumors and disorders.
  • Expected expiration: October 28th in 2021
  • Creation date: October 29th in 1997
  • Renew date: August 31st in 2016
Gamma Knife – CENTRO DE TRATAMIENTO DE TUMORES CEREBRALES
http://pageoverview.com/website-report/gammaknife.com.ec
Gamma Knife®, también identificada como SRS o radiocirugía estereotáctica, es una cirugía de alta tecnología que ha sido diseñada para aplicar –con extrema precisión– altas dosis de radiación, enfocando específicamente el tumor, gracias a lo cual se ocasiona un daño mínimo del tejido circundante, es posible tratar múltiples tumores en una sola sesión o atender la reaparición de estos en subsiguientes sesiones de radiocirugía, la disminución de efectos secundarios de quienes son tratados bajo esta revolucionaria técnica quirúrgica.
  • Creation date: February 13th in 2017
  • Expected expiration: February 13th in 2020
  • Google Analytics: 57677460-5
Jevtana® (cabazitaxel) Injection | Advanced Prostate Cancer
http://pageoverview.com/website-report/jevtana.com
Jevtana® (cabazitaxel) Injection is indicated for treatment of patients with hormone refractory metastatic prostate cancer previously treated with a docetaxel-containing treatment regimen.
  • Expected expiration: July 23rd in 2018
  • Creation date: July 23rd in 2002
  • Renew date: July 19th in 2016
Choose GLIVEC® (imatinib) for KIT+ GIST
http://pageoverview.com/website-report/glivec.com
GLIVEC® (imatinib) is indicated for the treatment of unresectable and/or metastatic and adjuvant KIT+ GIST.
  • Expected expiration: June 22nd in 2018
  • Creation date: June 22nd in 2000
  • Renew date: May 21st in 2016
metastatic mama | on having cancer and baby at the same time
http://pageoverview.com/website-report/metastaticmama.wordpress.com
on having cancer and baby at the same time
  • Google Analytics: 52447-2
Vectibix® (panitumumab) for Wild-Type RAS mCRC | HCP
http://pageoverview.com/website-report/vectibix.com
Learn about Vectibix® (panitumumab): an FDA-approved 1st- & 3rd-line treatment option for patients with WT RAS metastatic colorectal cancer (mCRC).
  • Expected expiration: October 5th in 2018
  • Creation date: October 5th in 2005
  • Renew date: September 3rd in 2017
Treatment for certain lung, stomach, and colorectal tumors | CYRAMZA(R) (ramucirumab)
http://pageoverview.com/website-report/cyramza.com
CYRAMZA® (ramucirumab), combined with other medications, is used for the treatment of patients with metastatic non-small cell lung cancer (NSCLC), advanced gastric cancer, gastroesophageal junction (GEJ) cancer, and metastatic colorectal cancer (CRC).
  • Expected expiration: October 5th in 2018
  • Creation date: October 5th in 2011
  • Renew date: October 1st in 2017
The American Association of Endocrine Surgeons - Patient Education Site
http://pageoverview.com/website-report/endocrinediseases.org
The American Association of Endocrine Surgeons is dedicated to the diagnosis, treatment, and study of endocrine disease. We created this site to help you and your loved ones find comprehensive, unbiased information about these diseases. Our goal is to provide you with all the knowledge you need to find the best possible care.
  • Expected expiration: October 16th in 2018
  • Creation date: October 16th in 2010
  • Renew date: August 21st in 2016
  • Google Analytics: 25839029-1
Prostate Cancer Foundation of Australia | PCFA
http://pageoverview.com/website-report/pcfa.org.au
PCFA is a broad based community organisation dedicated to reducing the impact of prostate cancer on Australian men, their partners and families
  • Google Analytics: 23518974-2
  • AddThis User: ra-51baa4744fe323b0
ONIVYDE® (irinotecan liposome injection) | MM-398 | Official Site
http://pageoverview.com/website-report/onivyde.com
ONIVYDE® (irinotecan liposome injection) in combination for patients with metastatic pancreatic cancer previously treated with gemcitabine. See Important Safety Information, including Boxed Warning.
  • Expected expiration: July 1st in 2025
  • Creation date: July 1st in 2013
  • Renew date: June 15th in 2017
  • Google Analytics: 68690796-1
Most Comprehensive Bowel Cancer Resource - Bowel Cancer Australia
http://pageoverview.com/website-report/bowelcanceraustralia.org
Bowel Cancer Australia is dedicated to prevention, early diagnosis, research, quality treatment and care for everyone affected by bowel cancer (also known as colorectal cancer).
  • Expected expiration: April 11th in 2024
  • Creation date: April 11th in 2007
  • Renew date: December 31st in 2015
OPDIVO® (nivolumab) | HCP | Metastatic Urothelial Carcinoma (mUC)
http://pageoverview.com/website-report/opdivoinformationhcp.com
OPDIVO® (nivolumab), for treatment of patients with previously treated locally advanced or metastatic urothelial carcinoma. See Indication and Important Safety Information.
  • Expected expiration: October 10th in 2018
  • Creation date: October 10th in 2016
  • Renew date: October 6th in 2017
Prostate Cancer Foundation of Australia - PCFA
http://pageoverview.com/website-report/prostate.org.au
PCFA is a broad based community organisation dedicated to reducing the impact of prostate cancer on Australian men, their partners and families
  • Google Analytics: 23518974-2
  • AddThis User: ra-51baa4744fe323b0
GIOTRIF® (afatinib) - | Boehringer Ingelheim
http://pageoverview.com/website-report/giotrif.com
GIOTRIF® (afatinib) -
  • Expected expiration: June 20th in 2018
  • Creation date: June 20th in 2007
  • Renew date: June 19th in 2016
  • Google Analytics: 44006287-1
0.0241 // 2024-05-05 19:30:31
All Rights reserved 2018 © PageOverview.com